skip to Global Navigation Bar
skip to main content
HOME
CONTACT US
SITEMAP
KOREAN
Global Business
Introduction
Strategy
Manufacturing
Contact Us
R&D
Introduction
Global R&D Centers
R&D Organization
Pipeline
CDMO
Introduction
Manufacturing Sites
Business Model
Service Range
Products
Global Brand
Products Search
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
About Us
Company Profile
CEO Message
Recruitment
Press Release
Company Profile
CEO Message
Recruitment
Press Release
News
PR Video
Home > About Us > Press Release >
News
뉴스
No
Subject
Data
254
Daewoong Pharmaceutical presents its research results on ‘treatments for fibrosis and autoimmune disease’ at ACR
2018-10-25
253
Daewoong Pharmaceutical holds Nabota Overseas Doctor Training Program ‘NMC FALL 2018 IN KOREA’
2018-10-22
252
Daewoong Pharmaceutical – Daewoong Bio Participate in CPHI 2018 to meet global drug representatives
2018-10-16
251
Daewoong Pharmaceutical and Evolus working together to launch Nabota
2018-10-05
250
FDA resumes review of Daewoong Pharmaceutical’s Nabota
2018-08-30
249
Nabota received approval from Health Canada
2018-08-20
248
Daewoong Pharmaceutical’s Nabota, Exposed latest clinical study result and treatment regimen at IMCAS ASIA 2018
2018-07-18
247
Daewoong Pharmaceutical successfully held ‘NABOTA SEOUL 2018’
2018-07-06
246
Daewoong’s Manufacturing Facility for Nabota acquires EU GMP Approval
2018-06-19
245
The Nabota Manufacturing Facility acquires GMP Approval from Health Canada
2018-05-24
1
/
2
/
3
/
4
/
5
/
6
/
7
/
8
/
9
/
10
/
News Search
subject
content
Home > About Us > Press Release > News
Home > About Us > Press Release > News